130 related articles for article (PubMed ID: 14733888)
1. Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOI clorgyline.
Culver KE; Szechtman H
Horm Behav; 2004 Jan; 45(1):23-30. PubMed ID: 14733888
[TBL] [Abstract][Full Text] [Related]
2. Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.
Culver KE; Szechtman H
Psychopharmacology (Berl); 2003 May; 167(2):211-8. PubMed ID: 12652347
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition.
Culver KE; Rosenfeld JM; Szechtman H
Neuropharmacology; 2002 Sep; 43(3):385-93. PubMed ID: 12243768
[TBL] [Abstract][Full Text] [Related]
4. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats.
Culver KE; Rosenfeld JM; Szechtman H
Psychopharmacology (Berl); 2000 Aug; 151(2-3):202-10. PubMed ID: 10972466
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments.
Dvorkin A; Culver KE; Szechtman H
Psychopharmacology (Berl); 2006 Jul; 186(4):534-43. PubMed ID: 16758240
[TBL] [Abstract][Full Text] [Related]
6. Clorgyline-induced modification of behavioral sensitization to quinpirole: effects on local cerebral glucose utilization.
Richards TL; Pazdernik TL; Levant B
Brain Res; 2007 Jul; 1160():124-33. PubMed ID: 17573047
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole.
Culver KE; Szechtman H
Eur J Pharmacol; 1997 Nov; 339(2-3):109-11. PubMed ID: 9473123
[TBL] [Abstract][Full Text] [Related]
8. Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.
Culver KE; Szechtman H; Levant B
Eur J Pharmacol; 2008 Sep; 592(1-3):67-72. PubMed ID: 18644362
[TBL] [Abstract][Full Text] [Related]
9. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
Johnson EF; Szechtman H
Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
[TBL] [Abstract][Full Text] [Related]
10. Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model.
Szechtman H; Culver K; Eilam D
Pol J Pharmacol; 1999; 51(1):55-61. PubMed ID: 10389145
[TBL] [Abstract][Full Text] [Related]
11. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole.
Beerepoot P; Lam V; Luu A; Tsoi B; Siebert D; Szechtman H
Neurosci Lett; 2008 Dec; 446(2-3):101-4. PubMed ID: 18824069
[TBL] [Abstract][Full Text] [Related]
12. Neonatal immune system activation with lipopolysaccharide enhances behavioural sensitization to the dopamine agonist, quinpirole, in adult female but not male rats.
Tenk CM; Foley KA; Kavaliers M; Ossenkopp KP
Brain Behav Immun; 2007 Oct; 21(7):935-45. PubMed ID: 17449223
[TBL] [Abstract][Full Text] [Related]
13. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole.
Jung TD; Jung PS; Raveendran L; Farbod Y; Dvorkin-Gheva A; Sakic B; Surette MG; Szechtman H
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):211-224. PubMed ID: 29194070
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism.
Szechtman H; Talangbayan H; Canaran G; Dai H; Eilam D
Psychopharmacology (Berl); 1994 Jun; 115(1-2):95-104. PubMed ID: 7862919
[TBL] [Abstract][Full Text] [Related]
15. Locomotor sensitization to quinpirole in rats: effects of drug abstinence and sex.
Szumlinski KK; Goodwill AM; Szechtman H
Psychopharmacology (Berl); 2000 Oct; 152(3):304-11. PubMed ID: 11105941
[TBL] [Abstract][Full Text] [Related]
16. Effects of monoamine oxidase inhibitors and dopamine agonists on the behavior of mammal- and frog-eating snakes.
Temple JG; Barthalmus GT
Physiol Behav; 1994 May; 55(5):927-33. PubMed ID: 7912837
[TBL] [Abstract][Full Text] [Related]
17. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
Perreault ML; Seeman P; Szechtman H
Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829
[TBL] [Abstract][Full Text] [Related]
18. Basal local cerebral glucose utilization is not altered after behavioral sensitization to quinpirole.
Richards TL; Pazdernik TL; Levant B
Neurosci Lett; 2007 Dec; 429(2-3):165-8. PubMed ID: 17997222
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole.
Lomanowska A; Gormley S; Szechtman H
Pharmacol Biochem Behav; 2004 Mar; 77(3):617-22. PubMed ID: 15006474
[TBL] [Abstract][Full Text] [Related]
20. Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms.
Perreault ML; Graham D; Bisnaire L; Simms J; Hayton S; Szechtman H
Neuropsychopharmacology; 2006 Sep; 31(9):1967-81. PubMed ID: 16237381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
